Viome Life Sciences, a systems biology company aiming to help individuals improve their health, has raised $54M in a pre-series C convertible funding with participation from existing investors and new investors.

This raise follows a $56M series B round announced in November 2019, bringing Viome's total funds raised to date to over $125M.

Returning investors for this round include Khosla Ventures, West River Group, Glico, Physician Partners, and Bold Capital Group. Ocgrow Ventures also participated in this round as a new investor.